Pharmaceutical and biotechnology companies Pfizer and BioNTech announced Saturday that updated versions of their vaccines that were adapted to the omicron variant of COVID-19 deliver a “substantially higher immune response” against the strain. Studies “found that a booster dose of both Omicron-adapted vaccine candidates elicited a substantially higher immune response against Omicron BA.1 as compared to the companies’ current COVID-19 […]
